Differences in Salivary Flow Level, Xerostomia, and Flavor Alteration in Mexican HIV Patients Who Did or Did Not Receive Antiretroviral Therapy

Table 4

Xerostomia evaluation between groups.

	With HAART		Without HAART		Significance
	𝑛	%	𝑛	%
Humidity
No	115	70.6	48	29.4	P = 0.211^Δ
Mild	21	72.4	8	27.6
Moderate	26	56.5	20	43.5
Grave	17	58.6	12	41.4
Total	179	67	88	33
Discomfort
No	144	67	71	33	𝑃=0.705^¶
Mild	14	73.7	5	26.3
Moderate	14	70	6	30
Grave	7	53.8	6	46.2
Total	179	67	88	33
Speaking
No	154	70	66	30	𝑃=0.051^¶
Mild	13	61.9	8	38.1
Moderate	6	37.5	10	62.5
Grave	6	60	4	40
Total	179	67	88	33
Eating
No	155	72.1	60	27.9	P = 0.005^Δ
Mild	9	47.4	10	52.6
Moderate	8	44.4	10	55.6
Grave	7	46.7	8	53.3
Total	179	67	88	33

Resource: Civil Hospital “Fray Antonio Alcalde” HIV Unit.
^Δ𝜒² test.
¶Fisher’s exact test.
Confidence interval percentage of 95%.